These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 36338983)
1. Calreticulin as a prognostic biomarker and correlated with immune infiltrate in kidney renal clear cell carcinoma. Sun M; Qi S; Wu M; Xia W; Xiong H Front Genet; 2022; 13():909556. PubMed ID: 36338983 [No Abstract] [Full Text] [Related]
2. LPAR2 correlated with different prognosis and immune cell infiltration in head and neck squamous cell carcinoma and kidney renal clear cell carcinoma. Sun K; Chen RX; Li JZ; Luo ZX Hereditas; 2022 Mar; 159(1):16. PubMed ID: 35241179 [TBL] [Abstract][Full Text] [Related]
3. BAG3 as a novel prognostic biomarker in kidney renal clear cell carcinoma correlating with immune infiltrates. Gong B; Huang Y; Wang Z; Wan B; Zeng Y; Lv C Eur J Med Res; 2024 Feb; 29(1):93. PubMed ID: 38297320 [TBL] [Abstract][Full Text] [Related]
4. Diagnostic and prognostic role of basic leucine zipper transcription factor in kidney renal clear cell carcinoma. Zhang H; Zhang H; Hu Y; Huang B; Chen J; Chen L Transl Androl Urol; 2022 Feb; 11(2):238-252. PubMed ID: 35280662 [TBL] [Abstract][Full Text] [Related]
5. Calreticulin, a potential coregulator of immune checkpoints and biomarker associated with tumor microenvironment and clinical prognostic significance in breast invasive carcinoma. Lin J; Chen Y; Zhang Z; Qi F; Zhang M Environ Toxicol; 2024 May; 39(5):2717-2731. PubMed ID: 38247288 [TBL] [Abstract][Full Text] [Related]
6. Comprehensive analysis of MFN2 as a prognostic biomarker associated with immune cell infiltration in renal clear cell carcinoma. Cheng L; Wang Z; Nie L; Yang C; Huang H; Lin J; Zhuo D Int Immunopharmacol; 2022 Oct; 111():109169. PubMed ID: 36007389 [TBL] [Abstract][Full Text] [Related]
7. Decreased expression of HADH is related to poor prognosis and immune infiltration in kidney renal clear cell carcinoma. Jiang H; Chen H; Wan P; Chen N Genomics; 2021 Nov; 113(6):3556-3564. PubMed ID: 34391866 [TBL] [Abstract][Full Text] [Related]
8. C1QC is a prognostic biomarker with immune-related value in kidney renal clear cell carcinoma. Yao W; Liu H; Xu F; Cai Z; Hang L; Lu M; Zhao Y; Yang C; Zong Y Front Genet; 2023; 14():1109991. PubMed ID: 36992705 [No Abstract] [Full Text] [Related]
9. Pseudogene HSPA7 is a poor prognostic biomarker in Kidney Renal Clear Cell Carcinoma (KIRC) and correlated with immune infiltrates. Ding C; He R; Zhang J; Dong Z; Wu J Cancer Cell Int; 2021 Aug; 21(1):435. PubMed ID: 34412642 [TBL] [Abstract][Full Text] [Related]
10. CTHRC1 Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Kidney Renal Papillary Cell Carcinoma and Kidney Renal Clear Cell Carcinoma. Zhou F; Shen D; Xiong Y; Cheng S; Xu H; Wang G; Qian K; Ju L; Zhang X Front Oncol; 2020; 10():570819. PubMed ID: 33628726 [TBL] [Abstract][Full Text] [Related]
11. GRAMD1A Is a Biomarker of Kidney Renal Clear Cell Carcinoma and Is Associated with Immune Infiltration in the Tumour Microenvironment. Liu Y; Fu S; Zhang Z; Wang S; Cheng X; Li Z; Ding Y; Sun T; Ma M Dis Markers; 2022; 2022():5939021. PubMed ID: 35860689 [TBL] [Abstract][Full Text] [Related]
12. Prognostic and Diagnostic Values of Semaphorin 5B and Its Correlation With Tumor-Infiltrating Immune Cells in Kidney Renal Clear-Cell Carcinoma. Ding J; Zhao S; Chen X; Luo C; Peng J; Zhu J; Shen Y; Luo Z; Chen J Front Genet; 2022; 13():835355. PubMed ID: 35480320 [No Abstract] [Full Text] [Related]
13. OCLN as a novel biomarker for prognosis and immune infiltrates in kidney renal clear cell carcinoma: an integrative computational and experimental characterization. Jia Z; Kong Y; Wang C; Fu Z; Tian Z; Sun Y; Lin Y; Huang Y Front Immunol; 2023; 14():1224904. PubMed ID: 37809090 [TBL] [Abstract][Full Text] [Related]
14. Low Xie Z; Chen N Transl Cancer Res; 2023 Nov; 12(11):3045-3060. PubMed ID: 38130311 [TBL] [Abstract][Full Text] [Related]
15. SOX11 as a prognostic biomarker linked to m6A modification and immune infiltration in renal clear cell carcinoma. Wang K; Chen X; Liu Y; Meng X; Zhou L Transl Cancer Res; 2024 Jul; 13(7):3536-3555. PubMed ID: 39145091 [TBL] [Abstract][Full Text] [Related]
16. NCKAP1 as a prognostic and immunological biomarker: pan-cancer analysis and validation in renal clear cell carcinoma. Liang X; Hong A; Shen R; Zhu M; Tian W Am J Transl Res; 2024; 16(8):4083-4100. PubMed ID: 39262720 [TBL] [Abstract][Full Text] [Related]
17. miR-21-5p/PRKCE axis implicated in immune infiltration and poor prognosis of kidney renal clear cell carcinoma. Wang J; Jin J; Liang Y; Zhang Y; Wu N; Fan M; Zeng F; Deng F Front Genet; 2022; 13():978840. PubMed ID: 36186442 [TBL] [Abstract][Full Text] [Related]
18. ARPC1B is a novel prognostic biomarker for kidney renal clear cell carcinoma and correlates with immune infiltration. Tang YF; Qiao B; Huang YB; Wang M Front Mol Biosci; 2023; 10():1202524. PubMed ID: 37795220 [No Abstract] [Full Text] [Related]
19. Decreased expression of Liu W; Xiao Z; Dong M; Li X; Huang Z Oncol Lett; 2024 Mar; 27(3):97. PubMed ID: 38288038 [TBL] [Abstract][Full Text] [Related]
20. Downregulation of RAB17 have a poor prognosis in kidney renal clear cell carcinoma and its expression correlates with DNA methylation and immune infiltration. Zeng Z; Zhang Z; Cheng X; Yang H; Gong B; Zhou X; Zhang C; Wang X; Wang G Cell Signal; 2023 Sep; 109():110743. PubMed ID: 37269962 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]